NEW DELHI (Reuters) – Pfizer Inc has applied for emergency use authorization of its coronavirus vaccine in India, media said on Sunday, the first to do so in a country with the world’s second highest number of infections.
(Reporting by Mayank Bhardwaj; Editing by Clarence Fernandez)
